High-density lipoproteins after acute coronary syndromes: evaluation of residual risk.

نویسندگان

  • Lorenzo Fácila
  • Julio Núñez
  • Juan Sanchis
  • Alberto Cordero
  • Oscar Fabregat-Andrés
  • Salvador Morell
چکیده

T1 (HDL<33 mg/dL) Baseline characteristics and cardiovascular risk factors Age, years 62.1 (13) Men 86.4 Smokers 54.4 Ex-smokers 20.1 Hypertension 59.2 Dyslipidemia 31.4 Diabetes mellitus 36.1 PHIHD 20.1 Laboratory values on admission Cholesterol, mg/dL 169.6 (37.2) LDL, mg/dL 112.5 (30.9) HDL, mg/dL 28.2 (3.7) Triglycerides, mg/dL 153.3 (87.3) Glucose, mg/dL 132.8 (55.3) Features of the acute coronary syndrome Killip class on admission 1.43 (0.77) Troponin, ng/L 66.3 (38.7) Lymphocytes, % 18.5 (13.9) Treatment at discharge Statin at discharge 42.3 Antiplatelet agent at discharge 95.9 Beta blocker 49.7 Long-term outcome Reinfarction 21.3 Death 22.5

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Acute Coronary Syndromes Compendium

Lipoproteins represent major risk factors, both positive and negative, for atherosclerotic cardiovascular disease. The major plasma lipid traits, low-density lipoprotein cholesterol (LDL-C), triglycerides, and high-density lipoprotein cholesterol (HDL-C) are all predictive of cardiovascular risk and have been considered targets for therapeutic intervention. Here, we specifically consider the ro...

متن کامل

Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit.

Randomized trials have established that statin treatment reduces coronary events in primary prevention and in patients with stable coronary artery disease. In unstable coronary artery disease, however, the pathophysiological background is distinct, and the potential benefits of statin therapy have not been evaluated until recently. Data from animal models and clinical studies indicate that stat...

متن کامل

Statin Therapy in Acute Coronary Syndromes

Randomized trials have established that statin treatment reduces coronary events in primary prevention and in patients with stable coronary artery disease. In unstable coronary artery disease, however, the pathophysiological background is distinct, and the potential benefits of statin therapy have not been evaluated until recently. Data from animal models and clinical studies indicate that stat...

متن کامل

Prediction of MACE After ACS

Current prevention of major adverse cardiovascular events (MACE) after acute coronary syndromes (ACS) is based on aggressive medical therapy, and guideline-driven treatment of traditional coronary risk factors. These include achieving low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, blood pressure, and glycosylated hemoglobin target levels, smoking cessation, and physi...

متن کامل

Low levels of high-density lipoproteins cholesterol are independently associated with acute coronary heart disease in patients hospitalized for chest pain.

INTRODUCTION AND OBJECTIVES The role of high-density lipoproteins in the context of acute chest pain has not been well characterized. The objective of this study was to determine the relative contribution of lipid profile to the risk of acute coronary syndrome in patients admitted to a cardiology ward for chest pain. METHODS We included all consecutive admissions in a single cardiology depart...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Revista espanola de cardiologia

دوره 66 1  شماره 

صفحات  -

تاریخ انتشار 2013